These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6150816)

  • 1. The pharmacokinetics of indecainide in mice, rats, dogs, and monkeys.
    Lindstrom TD; Whitaker GW
    Drug Metab Dispos; 1984; 12(6):683-90. PubMed ID: 6150816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of the antiarrhythmic agent, indecainide, in rats, dogs, and monkeys.
    Lindstrom TD; Lacefield WB; Whitaker GW
    Drug Metab Dispos; 1984; 12(6):691-7. PubMed ID: 6150817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of a novel butylated hydroxytoluene-thiazolidinone CNS antiischemic agent LY256548 in rats, mice, dogs, and monkeys.
    Ruterbories KJ; Lindstrom TD
    Drug Metab Dispos; 1990; 18(5):674-9. PubMed ID: 1981719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the absorption, distribution, metabolism, and excretion of the dopamine (D2) agonist, quinelorane, in rats, mice, dogs, and monkeys.
    Manzione BM; Bernstein JR; Franklin RB
    Drug Metab Dispos; 1991; 19(1):54-60. PubMed ID: 1673422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption, distribution and excretion of 2,4-diamino-6-(2,5-dichlorophenyl)-s-triazine maleate in rats, dogs and monkeys.
    Ando T; Momota K; Sugiyama M
    Arzneimittelforschung; 1986 Aug; 36(8):1221-8. PubMed ID: 3778559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of (5H-dibenzo [a,d]cyclohepten-5-ylidene)acetic acid in laboratory animals.
    Schillings RT; Sisenwine SF
    Drug Metab Dispos; 1986; 14(4):405-12. PubMed ID: 2873986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
    Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
    Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and tissue levels of furosemide in dogs and monkeys following single and multiple oral doses.
    Yakatan GJ; Maness DD; Scholler J; Johnston JT; Novick WJ; Doluisio JT
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):465-82. PubMed ID: 109903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic disposition of etodolac in rats, dogs, and man.
    Cayen MN; Kraml M; Ferdinandi ES; Greselin E; Dvornik D
    Drug Metab Rev; 1981; 12(2):339-62. PubMed ID: 6461537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, tissue distribution, and excretion of sitafloxacin, a new fluoroquinolone antibiotic, in rats, dogs, and monkeys.
    Tachibana M; Tanaka M; Mitsugi K; Jin Y; Takaichi M; Okazaki O
    Arzneimittelforschung; 2004; 54(12):898-905. PubMed ID: 15646375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeys.
    Cayen MN; Hicks DR; Ferdinandi ES; Kraml M; Greselin E; Dvornik D
    Drug Metab Dispos; 1985; 13(4):412-9. PubMed ID: 2863103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition of a new nonsteroidal anti-inflammatory agent, S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid, in rats, dogs and monkeys.
    Konishi T; Okada S; Nishikawa H; Esumi Y; Kitamura S; Tatsumi K
    Arzneimittelforschung; 1998 Mar; 48(3):266-74. PubMed ID: 9553685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.